Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 4.52%63.53B | 4.62%240.34B | 6.31%60.78B | 8.33%229.71B | -4.61%61.67B | 11.08%53.54B | 8.15%57.33B | 23.77%57.18B | 22.75%212.04B | 34.97%64.64B |
| Cost of revenue | 3.30%36.73B | 2.17%141.78B | 3.73%35.56B | 5.91%138.77B | -10.76%37.92B | 7.30%31.75B | 7.85%34.82B | 28.59%34.28B | 29.51%131.02B | 45.49%42.49B |
| Gross profit | 6.22%26.8B | 8.37%98.56B | 10.17%25.23B | 12.25%90.95B | 7.20%23.75B | 17.10%21.79B | 8.62%22.51B | 17.21%22.9B | 13.20%81.02B | 18.53%22.15B |
| Operating expense | 9.54%20.51B | 5.58%77.78B | 6.69%18.73B | 8.21%73.66B | 4.36%20.2B | 4.54%17.35B | 13.31%18.56B | 11.53%17.55B | 10.34%68.07B | 14.69%19.36B |
| Staff costs | ---- | 3.53%26.25B | ---- | 2.45%25.36B | ---- | ---- | ---- | ---- | 9.94%24.75B | ---- |
| Selling and administrative expenses | ---- | 5.75%21.73B | ---- | 6.95%20.55B | ---- | ---- | ---- | ---- | 10.65%19.21B | ---- |
| -Selling and marketing expense | ---- | 5.79%16.92B | ---- | 7.19%15.99B | ---- | ---- | ---- | ---- | 10.48%14.92B | ---- |
| -General and administrative expense | ---- | 5.62%4.81B | ---- | 6.12%4.56B | ---- | ---- | ---- | ---- | 11.24%4.29B | ---- |
| Depreciation and amortization | ---- | 9.21%2.99B | ---- | 9.09%2.74B | ---- | ---- | ---- | ---- | 18.25%2.51B | ---- |
| -Depreciation | ---- | 9.21%2.99B | ---- | 9.09%2.74B | ---- | ---- | ---- | ---- | 18.25%2.51B | ---- |
| Other operating expenses | ---- | 7.13%26.8B | ---- | 15.84%25.02B | ---- | ---- | ---- | ---- | 9.67%21.6B | ---- |
| Operating profit | -3.34%6.28B | 20.25%20.78B | 21.59%6.5B | 33.47%17.28B | 26.88%3.55B | 120.55%4.44B | -9.07%3.95B | 40.77%5.35B | 31.08%12.95B | 54.28%2.79B |
| Net non-operating interest income (expenses) | -340.00%-24M | 118.11%23M | 113.33%10M | -154.00%-127M | 136.17%17M | 0.00%-18M | -418.75%-51M | -7,400.00%-75M | -231.58%-50M | -491.67%-47M |
| Non-operating interest income | -16.33%41M | 12.50%144M | -2.00%49M | 20.75%128M | 9.30%47M | -141.18%-14M | 150.00%45M | 354.55%50M | -13.11%106M | 34.38%43M |
| Non-operating interest expense | 66.67%65M | -52.55%121M | -68.80%39M | 63.46%255M | -66.67%30M | -92.31%4M | 4,700.00%96M | 941.67%125M | 85.71%156M | 350.00%90M |
| Net investment income | -79.15%177M | -98.32%32M | -18.05%849M | 132.52%1.91B | 2.55%563M | 119.57%101M | 152.38%209M | 65.76%1.04B | 85.75%821M | 14.85%549M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 119M | 777.36%465M | 0 | -8.62%53M | 0 | 0 | 0 | 211.76%53M | -77.69%58M | -81.60%39M |
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -90.00%1M | -99.51%2M | -97.69%10M | 180.20%409M | 15.81%-426M | 3,542.86%255M | 2,214.29%148M | 10,900.00%432M | -62.94%-510M | -15.79%-506M |
| Less:Restructuring and mergern&acquisition | ---- | --0 | ---- | -79.91%92M | -99.78%1M | ---- | ---- | ---- | --458M | --458M |
| Less:Other special charges | 90.00%-1M | 97.40%-14M | 97.69%-10M | -1,222.92%-539M | 779.55%387M | -4,842.86%-346M | -2,214.29%-148M | -10,900.00%-432M | 132.65%48M | 291.30%44M |
| Less:Write off | ---- | -68.42%12M | ---- | 850.00%38M | ---- | ---- | ---- | ---- | -99.13%4M | ---- |
| Other non-operating income (expenses) | 420.00%208M | 60.70%503M | 81.82%40M | -2.19%313M | -29.70%116M | 825.00%58M | 105.26%117M | -79.25%22M | -45.30%320M | -36.54%165M |
| Income before tax | -8.72%6.76B | 9.92%21.8B | 8.73%7.41B | 46.02%19.84B | 27.49%3.81B | 136.99%4.84B | 8.94%4.37B | 50.12%6.81B | 24.78%13.58B | 28.27%2.99B |
| Income tax | -17.68%1.81B | 17.83%6.38B | 4.18%2.2B | 51.81%5.41B | -8.49%819M | 113.33%1.25B | 15.70%1.24B | 107.59%2.11B | 15.78%3.57B | 30.09%895M |
| Net income | -4.97%4.96B | 6.95%15.43B | 10.77%5.21B | 43.96%14.42B | 42.75%2.99B | 146.74%3.59B | 6.45%3.13B | 33.57%4.71B | 28.35%10.02B | 27.57%2.1B |
| Net income continuous operations | -4.95%4.96B | 6.95%15.43B | 10.77%5.21B | 43.97%14.42B | 42.86%2.99B | 146.50%3.59B | 6.49%3.14B | 33.57%4.71B | 28.33%10.02B | 27.51%2.1B |
| Noncontrolling interests | -5.13%74M | 62.50%182M | 116.67%78M | 3.70%112M | -50.00%4M | -19.67%49M | 9.52%23M | 100.00%36M | 21.35%108M | -66.67%8M |
| Net income attributable to the company | -4.97%4.88B | 6.51%15.24B | 9.96%5.14B | 44.41%14.31B | 43.15%2.99B | 154.13%3.54B | 6.43%3.11B | 33.24%4.67B | 28.42%9.91B | 28.97%2.09B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -4.97%4.88B | 6.51%15.24B | 9.96%5.14B | 44.41%14.31B | 43.15%2.99B | 154.13%3.54B | 6.43%3.11B | 33.24%4.67B | 28.42%9.91B | 28.97%2.09B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -5.00%63.6 | 6.47%198.65 | 9.92%66.95 | 44.36%186.57 | 43.14%38.9567 | 154.01%46.1533 | 6.38%40.5533 | 33.19%60.9067 | 28.37%129.2367 | 28.89%27.2167 |
| Diluted earnings per share | -5.00%63.6 | 6.47%198.65 | 9.92%66.95 | 44.36%186.57 | 43.14%38.9567 | 153.96%46.1443 | 6.38%40.5533 | 33.19%60.9067 | 28.37%129.2367 | 28.89%27.2167 |
| Dividend per share | 0 | 25.00%50 | 0 | 71.43%40 | 112.50%28.3333 | 0 | 16.67%11.6667 | 0 | 16.67%23.3333 | 14.29%13.3333 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |